Compugen (CGEN) News Today $1.77 +0.01 (+0.57%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 23, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Compugen (CGEN)July 23, 2024 | prnewswire.comCompugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024June 19, 2024 | marketbeat.comStockNews.com Upgrades Compugen (NASDAQ:CGEN) to "Buy"StockNews.com raised Compugen from a "hold" rating to a "buy" rating in a research note on Wednesday.June 17, 2024 | prnewswire.comCompugen to Present at Upcoming Antibody Industrial SymposiumJune 11, 2024 | marketbeat.comStockNews.com Lowers Compugen (NASDAQ:CGEN) to HoldStockNews.com cut Compugen from a "buy" rating to a "hold" rating in a research note on Tuesday.June 2, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Sees Significant Decrease in Short InterestCompugen Ltd. (NASDAQ:CGEN - Get Free Report) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 1,730,000 shares, a decrease of 11.3% from the April 30th total of 1,950,000 shares. Based on an average daily trading volume, of 517,200 shares, the days-to-cover ratio is presently 3.3 days.May 30, 2024 | prnewswire.comCompugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating RilvegostomigMay 22, 2024 | markets.businessinsider.comCompugen’s Strategic Shift to PROC Program Merits a Buy RatingMay 22, 2024 | finance.yahoo.comEarnings Release: Here's Why Analysts Cut Their Compugen Ltd. (NASDAQ:CGEN) Price Target To US$5.00May 22, 2024 | marketbeat.comCompugen (NASDAQ:CGEN) Upgraded at StockNews.comStockNews.com raised shares of Compugen from a "hold" rating to a "buy" rating in a report on Tuesday.May 21, 2024 | msn.comCompugen Ltd. (NASDAQ:CGEN) Q1 2024 Earnings Call TranscriptMay 21, 2024 | marketbeat.comTruist Financial Cuts Compugen (NASDAQ:CGEN) Price Target to $4.00Truist Financial cut their price target on Compugen from $5.00 to $4.00 and set a "buy" rating for the company in a report on Tuesday.May 20, 2024 | finanznachrichten.deCompugen Ltd.: Compugen Reports First Quarter 2024 ResultsMay 20, 2024 | investorplace.comCGEN Stock Earnings: Compugen Misses EPS, Misses Revenue for Q1 2024May 20, 2024 | prnewswire.comCompugen Reports First Quarter 2024 ResultsMay 17, 2024 | msn.comCompugen Q1 2024 Earnings PreviewMay 16, 2024 | prnewswire.comCompugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic PotentialMay 15, 2024 | finanznachrichten.deCompugen Ltd.: Compugen Appoints David Silberman as Chief Financial OfficerMay 15, 2024 | marketwatch.comCompugen Names David Silberman Chief Financial OfficerMay 15, 2024 | prnewswire.comCompugen Appoints David Silberman as Chief Financial OfficerMay 14, 2024 | stocknews.com3 Biotech Stocks to Monitor for May MovesMay 6, 2024 | prnewswire.comCompugen to Release First Quarter 2024 Results on Monday, May 20, 2024April 29, 2024 | finance.yahoo.comWe're Not Worried About Compugen's (NASDAQ:CGEN) Cash BurnApril 25, 2024 | prnewswire.comCompugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024April 15, 2024 | stocknews.com3 Biotech Stocks with Potential Gains - Watch or Buy?April 14, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Sees Significant Increase in Short InterestCompugen Ltd. (NASDAQ:CGEN - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 2,090,000 shares, a growth of 11.8% from the March 15th total of 1,870,000 shares. Based on an average daily volume of 651,500 shares, the short-interest ratio is currently 3.2 days.April 11, 2024 | investing.comCompugen reports progress on cancer therapy COM503April 10, 2024 | prnewswire.comCompugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503April 3, 2024 | finance.yahoo.comCompugen to Participate in Two Upcoming Investor ConferencesApril 2, 2024 | finance.yahoo.comIs Compugen Ltd. (NASDAQ:CGEN) Trading At A 31% Discount?March 19, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Short Interest Down 9.4% in FebruaryCompugen Ltd. (NASDAQ:CGEN - Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 29th, there was short interest totalling 1,830,000 shares, a decrease of 9.4% from the February 14th total of 2,020,000 shares. Based on an average trading volume of 2,800,000 shares, the days-to-cover ratio is presently 0.7 days.March 16, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Buy Rating on Compugen (CGEN)March 11, 2024 | finance.yahoo.comCompugen Selected for two Oral Presentations at the Keystone Symposium on Cancer ImmunotherapyMarch 8, 2024 | seekingalpha.comCompugen Ltd. (CGEN) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | markets.businessinsider.comBuy Rating Justified by Compugen’s Positive Clinical Outlook and Financial StabilityMarch 7, 2024 | finance.yahoo.comCompugen Ltd. (NASDAQ:CGEN) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finanznachrichten.deCompugen Ltd.: Compugen Reports Fourth Quarter and Full Year 2023 ResultsMarch 6, 2024 | prnewswire.comCompugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024March 5, 2024 | msn.comCGEN Stock Earnings: Compugen Misses EPS, Beats Revenue for Q4 2023March 5, 2024 | sfgate.comCompugen: Q4 Earnings SnapshotMarch 5, 2024 | prnewswire.comCompugen Reports Fourth Quarter and Full Year 2023 ResultsMarch 4, 2024 | benzinga.comEarnings Preview For CompugenFebruary 27, 2024 | marketbeat.comCompugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving Average of $1.29Compugen (NASDAQ:CGEN) Share Price Passes Above 200-Day Moving Average of $1.29February 26, 2024 | finance.yahoo.comCompugen to Present at the Leerink Partners Global Biopharma Conference 2024February 26, 2024 | prnewswire.comCompugen to Present at the Leerink Partners Global Biopharma Conference 2024February 22, 2024 | benzinga.comCompugen Stock (NASDAQ:CGEN), Short Interest ReportFebruary 22, 2024 | benzinga.comCompugen Stock (NASDAQ:CGEN) Dividends: History, Yield and DatesFebruary 21, 2024 | finance.yahoo.comCompugen (CGEN) is a Great Momentum Stock: Should You Buy?February 20, 2024 | finance.yahoo.comCompugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024February 20, 2024 | prnewswire.comCompugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024 Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now. CGEN Media Mentions By Week CGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGEN News Sentiment▼0.630.62▲Average Medical News Sentiment CGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGEN Articles This Week▼31▲CGEN Articles Average Week Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Inhibrx News Black Diamond Therapeutics News C4 Therapeutics News Canopy Growth News Contineum Therapeutics News Esperion Therapeutics News Anavex Life Sciences News Editas Medicine News Aura Biosciences News Enanta Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGEN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGEN Stock Alerts